ZielBio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.itihealth.com
A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors
Phase 1
Completed
- Conditions
- Solid Tumor, AdultBiliary Cancer MetastaticOvarian Serous AdenocarcinomaOvarian Serous CystadenocarcinomaPancreatic Ductal; Adenocarcinoma
- Interventions
- First Posted Date
- 2021-10-12
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- ZielBio, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT05074472
- Locations
- 🇺🇸
Mayo Clinic Jacksonville, Jacksonville, Florida, United States
🇺🇸University of Virginia, Charlottesville, Virginia, United States
🇺🇸Mayo Clinic - Phoenix, Phoenix, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath